Exosome-Mitochondrial Hybrid Membrane with Targeted Delivery of CO Prevents Mitochondrial Dysfunction and Pyroptosis against Myocardial Ischemia-Reperfusion Injury
ACS Nano · 21.04.2026 · 20 (15) · 11724-11741
DOI: 10.1021/acsnano.5c21479 ↗Kurz gefasst
Fachartikel in der Zeitschrift ACS Nano, online erschienen am 07.04.2026. Verfasst von Lintao Wang und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing, Jiangsu 210008, China. Hauptthemen laut MEDLINE: Myocardial Reperfusion Injury, Pyroptosis, Carbon Monoxide, Exosomes. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 44 Literaturangaben. Gefördert von: China Postdoctoral Science Foundation, Medical Science and Technology Development Foundation, Nanjing Municipality Health Bureau, National Natural Science Foundation of China.
Abstract (Originalsprache)
Myocardial ischemia-reperfusion (I/R) injury exacerbates cardiac dysfunction and heart failure following clinical revascularization. The main mechanisms involve aberrant accumulation of reactive oxygen species (ROS) that induce mitochondrial dysfunction, trigger pyroptosis, and amplify immune-inflammatory responses. Herein, we developed exosome-mitochondrial hybrid membrane vessels to encapsulate carbon monoxide (EM@CO) for targeted delivery of CO to attenuate myocardial I/R injury. Due to the adhesive properties of exosomes and the homologous mitochondrial targeting capacity of the mitochondrial membrane (MM), EM@CO exhibits sequential targeting from infarcted myocardium to myocardial cell mitochondria. The released CO in mitochondria reduces abnormal mitochondrial ROS generation to maintain mitochondrial function, thereby decreasing mtDNA release and inhibiting pyroptosis in vitro and in vivo. Moreover, a single intravenous injection of EM@CO attenuates inflammatory amplification in cardiac tissue by promoting M1 to M2 macrophage polarization. It can effectively decrease the pro-inflammatory cytokine release and inhibit inflammation, thereby attenuating myocardial infarction and improving cardiac function. In summary, the findings of this study reveal the potential for restoring mitochondrial function through targeted gas therapy to eliminate reactive oxygen species (ROS) and inhibit cellular pyroptosis, which holds promise for ameliorating myocardial ischemia-reperfusion injury.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Cardiology, Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing, Jiangsu 210008, China.
- Nanjing Drum Tower Hospital Clinical College of Nanjing University of Chinese Medicine, Nanjing, Jiangsu 210008, China.
- Department of Pharmacy, Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing, Jiangsu 210008, China.
- School of Pharmaceutical Science, Nanjing Tech University, Nanjing, Jiangsu 211816, China.
- Department of Emergency Medicine, Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing, Jiangsu 210008, China.
- Department of Science and Technology, Nanjing Drum Tower Hospital Clinical College of Nanjing University of Chinese Medicine, Nanjing, Jiangsu 210008, China.
Förderung
- China Postdoctoral Science Foundation
- Medical Science and Technology Development Foundation, Nanjing Municipality Health Bureau
- National Natural Science Foundation of China
- Research Foundation of China International Medical Foundation
- Nanjing Drum Tower Hospital Cultivation Project for Youth Science Fund Project of NSFC
- Youth Training Program of Nanjing Traditional Chinese Medicine
- Clinical Trials from the Affiliated Drum Tower Hospital, Medical School of Nanjing University
Zitieren
APA
Wang, L., Shi, Q., Jiang, C., Xu, M., Wang, X., Ren, H., Wang, X., Fang, Q., Sun, J., Kang, L., Chen, X., Sha, D., & Ni, J. (2026). Exosome-Mitochondrial Hybrid Membrane with Targeted Delivery of CO Prevents Mitochondrial Dysfunction and Pyroptosis against Myocardial Ischemia-Reperfusion Injury. ACS Nano, 20(15), 11724-11741. https://doi.org/10.1021/acsnano.5c21479
Vancouver
Wang L, Shi Q, Jiang C, Xu M, Wang X, Ren H, et al. Exosome-Mitochondrial Hybrid Membrane with Targeted Delivery of CO Prevents Mitochondrial Dysfunction and Pyroptosis against Myocardial Ischemia-Reperfusion Injury. ACS Nano. 2026;20(15):11724-11741. doi:10.1021/acsnano.5c21479
BibTeX
@article{Wang2026,
author = {Wang, Lintao and Shi, Qianzhi and Jiang, Chenxiao and Xu, Mengyao and Wang, Xinyu and Ren, Hao and Wang, Xudong and Fang, Qijun and Sun, Jing and Kang, Lina and Chen, Xin and Sha, Dujuan and Ni, Jie},
title = {Exosome-Mitochondrial Hybrid Membrane with Targeted Delivery of CO Prevents Mitochondrial Dysfunction and Pyroptosis against Myocardial Ischemia-Reperfusion Injury},
journal = {ACS Nano},
year = {2026},
volume = {20},
number = {15},
pages = {11724--11741},
doi = {10.1021/acsnano.5c21479}
}
EUVIMED